PRODUCT DESCRIPTION:

An intramuscular androgenic preparation combines three testosterone esters—enanthate, cypionate, and propionate. It's specifically designated for testosterone replacement therapy in male hypogonadal disorders such as post-castration, eunuchoidism, or hypopituitarism, but is not suitable for female use due to suspected mammary or prostatic carcinoma.

COMPOSITION:

Each milliliter contains enanthate 188 mg, cypionate 187 mg, and propionate 25 mg.

DRUG CLASS:

Classified as anabolic/androgenic steroids.

DOSAGE:

Typically administered in doses ranging from 400 to 800 mg per week for males.

CONTRAINDICATIONS:

Known or suspected mammary or prostaticb16 carcinoma in the male. This medicine is not intended for use in female patients, children or pregnant women.

SIDE EFFECTS AND PRECAUTIONS:

Adverse reactions like excessive sexual stimulation, precocious sexual development in boys, and decreased ejaculatory volume have been associated with androgen therapy. Caution is recommended in patients with underlying conditions like cardiac failure, renal dysfunction, or hypertension, as androgens might induce salt and fluid retention. Additionally, Testo-Med usage in prepubertal boys requires vigilance to avoid early epiphyseal closure or premature sexual development.

STORAGE:

Keep in a cool, dry place away from light, and out of reach of children.